Redirecting cytotoxic T lymphocyte responses with T-cell receptor transgenes

By Morse Michael   Lyerly H Kim   Clay Timothy M  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 353-360

Informa Healthcare

Access to resources Recommend Favorite

The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide

By Chen Xiaohua   Liu Honghong   Tang Zhenghao   Yu Yongsheng   Zang Guoqing  

Acta Biochimica et Biophysica Sinica, Vol. 45, Iss. 3, 2013-03 ,pp. : 203-212

Oxford University Press

Access to resources Recommend Favorite

Broadly expressed tumour?associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy

By Bendle Gavin M   Holler Angelika   Downs Anne-Marie   Xue Shao-An   Stauss Hans J  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 9, 2005-09 ,pp. : 1183-1192

Informa Healthcare

Access to resources Recommend Favorite

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer management

By Movva Sujana   Verschraegen Claire  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 231-241

Informa Healthcare

Access to resources Recommend Favorite

Perforin-Enhancing Protein, a Low Molecular Weight Protein of Cytotoxic Lymphocyte Granules, Enhances Perforin Lysis

By Winkler U.   Fraser S.A.   Hudig D.  

Biochemical and Biophysical Research Communications, Vol. 236, Iss. 1, 1997-07 ,pp. : 34-39

Elsevier

Access to resources Recommend Favorite